Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy

Author： Hilmar Burchardi  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.12, 2004-01, pp. : 793-813

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The costs of medical care for patients with severe chronic illness varies across the US, but quality of care is not necessarily related to cost of care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost effectiveness of intensive statin therapy remains debatable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Neuropathic Pain: Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy

By O'Connor Alec B.  

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 95-112

Adis International

Access to resources Recommend Favorite

Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy

By Brown Patricia  

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1123-1142

Adis International

Access to resources Recommend Favorite

A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy

By Menzin Joseph  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 839-861

Adis International

Access to resources Recommend Favorite